Fig. 4
From: Cloaking nanoparticles with protein corona shield for targeted drug delivery
Ex vivo and in vivo efficiency of PCSN. a, b Fluorescence images of organs and tumors 48 h after intravenous injection and biodistribution of injected formulations in animals with SK-BR3 tumor xenograft from fluorescence intensity analysis. In vivo antitumor effects in different treatment groups loaded with camptothecin (CPT) (1.5 mg/kg of mice) (scale bar is 2 cm). c Growth curve of tumor volume after intravenous injection with various groups of carriers until day 21 (n = 6 mice per group, mean ± 1 day [n = 6 mice per group, mean ± SD, statistical significance was calculated by one-way analysis of variance, *P < 0.05, **P < 0.01]
